A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)

NCT00303485 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Post Menopausal Osteoporosis

Interventions

DRUG: Placebo
DRUG: Vitamin D and calcium supplementation
DRUG: ibandronate [Bonviva/Boniva]

Sponsor

Hoffmann-La Roche